A Study of JZP150 in Adults With Posttraumatic Stress Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Post Traumatic Stress Disorder

In brief

This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP150 in the treatment of adult participants with post-traumatic stress disorder (PTSD).

Key facts

Study ID

NCT05178316

Run by

Jazz Pharmaceuticals

People needed

282

Starts

2021-12-29

Expected to finish

2023-12-05

Last updated by the study team

2024-12-31

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants aged 18 to 70 years
• Participants must be outpatients with a primary diagnosis of Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) defined PTSD confirmed by the clinical interview
• PTSD is primary diagnosis

You may not qualify if…

• Acute or unstable medical condition, behavioral or psychiatric disorder (other than PTSD)
• Suicidal behavior in the past 2 years or active suicidal ideation in the past 6 months
• Ongoing traumatic event or exposure to a traumatic event <3 months prior to Screening
• Index event > 12 years
• Index event is combat trauma

Where it is running

• Sanro Clinical Research Group, LLC — Bryant, Arkansas, United States
• Woodland Research Northwest — Rogers, Arkansas, United States
• Clinical Innovations Inc. — Bellflower, California, United States
• Southern California Research, LLC — Beverly Hills, California, United States
• Behavioral Research Specialists, LLC — Glendale, California, United States
• Excell Research — Oceanside, California, United States
• NRC Research Institute — Orange, California, United States
• CITrials — Riverside, California, United States
• Clinical Innovations Inc. — Santa Ana, California, United States
• Collaborative Neuroscience Research, LLC — Torrance, California, United States
• Pacific Clinical Research Management Group LLC — Upland, California, United States
• MCB Clinical Research Center — Colorado Springs, Colorado, United States
• CT Clinical Research — Cromwell, Connecticut, United States
• Yale Center for Clinical Investigation: Church Street Research Unit (CSRU) — New Haven, Connecticut, United States
• Howard University Hospital, Clinical Research Unit — Washington D.C., District of Columbia, United States
• Sarkis Clinical Trials — Gainesville, Florida, United States
• Clinical Neuroscience Solutions, Inc. — Jacksonville, Florida, United States
• Accel Research Sites -Lakeland Clinical Research Unit — Lakeland, Florida, United States
• Accel Research Sites Network-St. Petersburg Clinical Research Unit — Largo, Florida, United States
• Premier Clinical Research Institute — Miami, Florida, United States
• EZY Medical Research Co — Miami, Florida, United States
• Behavioral Clinical Research, Inc — Miami Lakes, Florida, United States
• Clinical Neuroscience Solutions, Inc. — Orlando, Florida, United States
• Advanced Discovery Research — Atlanta, Georgia, United States
• NoesisPharma LLC — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.